China Approves Experimental Vaccine for use in Military

China // 29 June, 2020

Media are reporting that the AD5-nCoV vaccine, one of eight in development in China, has been approved for use in its military. The vaccine was approved for one year as of 25 June. Media are also reporting that the manufacturer, CanSino Biologics reported it was safe and showed at least some efficacy. A press release from CanSino notes that the vaccine was approved to enter Phase 1 Clinical Trial as of 17 March.

LATEST NEWS

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
Webinars

Pandemic Information Webinars
(Available to Pandemic Subscribers only)
Register for upcoming events
View/Download previous webinars